한글목차

전임상 이미징 시장 규모는 예측 기간 동안 5.9%의 연평균 복합 성장률(CAGR)로 확대되었으며, 2024년 9억 4,600만 달러에서 2029년에는 12억 5,900만 달러에 이를 것으로 예측됩니다.

시장 성장의 주요 요인은 신약 개발과 비침습적인 소동물 이미징 기술에 대한 시장 수요 증가, 전임상 연구를 지원하는 관민 이니셔티브 및 자금 제공 증가, 분자 이미징 분야의 기술 진보, 저비용 및 저렴한 가격 전 임상 이미징 시스템의 개발 등입니다.

제품별로 전임상 이미징 시장은 이미징 시스템, 시약, 소프트웨어로 구분됩니다. 이미징 시스템은 또한 광학 이미징, 핵 이미징, 마이크로 MRI, 마이크로 CT, 마이크로 초음파, 광 음향 이미징, 자성 입자 이미징으로 구분됩니다. 광학 이미징 분야는 작은 동물 이미징과 신약 탐색 프로젝트에서의 폭넓은 응용이 주인으로 최대 시장 점유율을 획득하고 있습니다. 광학 전임상 이미징의 보급에는 몇 가지 요인이 있습니다. 분자 이미징 기술의 진보는 연구자들이 정교한 정확한 이미징 능력을 제공하여이 분야를 크게 향상 시켰습니다.

전임상 이미징 시장은 용도별로 종양학, 순환기학, 신경학, 감염증학, 면역학·염증학 등으로 구분됩니다. 전임상 이미징 응용 분야에서 종양학은 가장 큰 점유율을 차지합니다. 이는 전임상 이미징을 통해 연구자가 같은 동물에서 종양 진행과 치료 반응을 장기간 추적할 수 있게 하는 등 여러 요인 때문입니다. 이것은 신약과 치료법의 효능을 평가하는데 종양학에서 특히 가치가 있습니다.

최종 사용자별로 전임상 이미징 시장은 제약·바이오테크놀러지 기업, 학술·연구센터, 이미징센터 등으로 구분됩니다. 예측 기간 동안 제약 및 생명 공학 기업 부문이 가장 큰 점유율을 차지합니다. 바이오테크놀러지 기업의 전임상 이미징 수요는 최근 꾸준히 증가하고 있으며 앞으로도 계속 성장할 것으로 예측되고 있습니다. 제약 및 생명 공학 기업 시장 수요 증가는 신흥 및 재흥 감염의 확산으로 인해 발생합니다. 전임상 이미징은 병원체에 대한 이해를 높이고 새로운 치료제와 백신의 개발에 도움이 되기 위해 필수적입니다.

이 보고서는 전 세계 임상 이미징 시장에 대해 조사했으며, 제품별, 용도별, 최종 사용자별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 소개
• 시장 역학
• 업계 동향
• 기술 분석
• 밸류체인 분석
• 생태계 분석
• Porter's Five Forces 분석
• 규제 상황
• 특허 분석
• 무역 분석
• 사례 연구 분석
• 2023-2024년의 주된 회의와 이벤트
• 주요 이해관계자와 구매 기준
• 미충족 요구의 분석
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 환급 시나리오
• 비즈니스 모델 분석
• 투자와 자금조달 시나리오

제6장 전임상 이미징 시장(제품별)

• 소개
• 이미징 시스템
• 시약
• 소프트웨어

제7장 전임상 이미징 시장(용도별)

• 소개
• 종양
• 심장병
• 신경
• 감염증
• 면역학과 염증
• 기타

제8장 전임상 이미징 시장(최종사용자별)

• 소개
• 제약·바이오테크놀러지 기업
• 학술연구센터
• 이미지 센터
• 기타

제9장 전임상 이미징 시장(지역별)

• 소개
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 구도

• 개요
• 주요 진입기업의 전략/비책
• 수익 분석
• 시장 점유율 분석
• 주요 시장 기업의 랭킹
• 기업평가 매트릭스: 주요 진입기업, 2023년
• 기업평가 매트릭스: 스타트업/중소기업, 2023년
• 평가 및 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오

제11장 기업 프로파일

• 주요 진출기업
  • BRUKER CORPORATION
  • REVVITY, INC.
  • OPTISCAN IMAGING LTD.
  • MEDISO LTD.
  • ASPECT IMAGING LTD.
  • MR SOLUTIONS
  • TRIFOIL IMAGING
  • MILABS BV
  • CUBRESA INC.
  • BERTHOLD TECHNOLOGIES GMBH & CO. KG
  • ADVANCED MOLECULAR VISION, INC.
  • SOFIE
  • ICONEUS
  • FUJIFILM VISUALSONICS, INC.
  • LI-COR BIOTECH, LLC
  • IVIM TECHNOLOGY CORP.
  • KUB TECHNOLOGIES
  • MEDIKORS INC.
  • VIEWORKS CO., LTD.
  • AI4R
• 기타 기업
  • ANALYTIK JENA GMBH CO. KG
  • ITHERA MEDICAL GMBH
  • SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
  • HAWKCELL SAS
  • MILTENYI BIOTEC

제12장 부록

영문목차

The preclinical imaging market is projected to reach USD 1,259 million by 2029 from USD 946 million in 2024, at a CAGR 5.9% during the forecast period. The market growth is mainly driven by factors such as increasing market demand for new drug development and noninvasive small-animal imaging techniques, growing number of public-private initiatives and funding to support preclinical researches, technological advancements in the field of molecular imaging, and development of low-cost & affordable preclinical imaging systems.

"Optical Imaging System accounted for the largest share of the market in the forecast period, by product type."

Based on product, the preclinical imaging market is segmented into imaging systems, reagents, and software. The imaging systems is further segmented into optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic imaging, and magnetic particle imaging. The optical imaging segment captured the largest market share, primarily due to its extensive application in small animal imaging and new drug discovery projects. Several factors have contributed to the growing adoption of optical preclinical imaging. Technological advancements in molecular imaging have significantly enhanced the field, offering researchers more sophisticated and precise imaging capabilities.

"Oncology segment accounted for the largest share of the market in the forecast period, by application."

Based on application, the preclinical imaging market is segmented into oncology, cardiology, neurology, infectious diseases, immunology and inflammation, and other applications. Among the preclinical imaging applications, oncology holds the largest share. This can be due to several factors such as preclinical imaging enables researchers to track tumor progression and treatment response in the same animal over time. This is particularly valuable in oncology for assessing the effectiveness of new drugs and therapies.

"The pharmaceutical and biotechnology companies segment accounted for the largest share of the market in the forecast period, by end user."

Based on end user, the preclinical imaging market is segmented into pharmaceutical & biotechnology companies, academic and research centers, imaging centers, and other end users. The pharmaceutical & biotechnology companies segment accounted for the largest share during the forecast period. The demand for preclinical imaging in biotech companies has been steadily rising in recent years and is projected to continue growing. This increasing market demand in pharmaceutical and biotech companies is driven by the spread of emerging and re-emerging infectious diseases. Preclinical imaging is essential for gaining a better understanding of pathogens and for aiding the development of new therapeutics and vaccines.

"Asia Pacific to register the highest growth in the preclinical imaging market in the forecast period."

The global preclinical imaging market is segmented into five major regions, namely, North America, Europe, APAC, Latin America, and Middle East & Africa. In 2023, Asia Pacific was expected to register the highest growth for preclinical imaging market in the forecast period. Factors such as lower research costs, less stringent regulatory guidelines, and increased government funding for the development of the research and development sector in these countries are making the region attractive for preclinical research studies. Consequently, the clinical research outsourcing (CRO) industry is thriving in emerging countries like China and India.

Breakdown of the supply-side, demand side, primary interviews by company type, designation, and region:

• By Supply Side: Tier 1 (25%), Tier 2 (5%), and Tier 3 (70%)
• By Designation: C-level Executives (27%), Director-level (18%), and Others (55%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and Middle East and Africa (5%)

The prominent players in this market are Bruker Corporation (US), Revvity, Inc. (US), MR Solutions (UK), Mediso Ltd. (UK), Trefoil Imaging (US), Fujifilm Visual Sonics (Canada), MILABS B.V. (Netherlands), Aspect Imaging Limited (US), Li-Cor Biosciences (US), ICONEUS (Paris), Advanced Molecular Vision (UK), IVIM Technology Corp. (South Korea), Cubresa, Inc. (Canada), Berthold Technologies GMBH & CO.KG (Germany), Sofie (US), Viewworks (Korea), AI4R (France), Kub Technologies (US), Medikor (US), and Miltenyi Biotech GmbH (Germany) . Players adopted organic as well as inorganic growth strategies such as new product launches, acquisitions, and expansions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage

The report studies the preclinical imaging market based on product type, application, end user, and region. The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total brain computer interface market. The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

• Analysis of key drivers (technological advancements in the field of molecular imaging, increasing market demand for noninvasive small-animal imaging techniques, growing number of public-private initiatives and funding to support preclinical researches, and development of low-cost & affordable preclinical imaging systems), restraints (strict regulation, significant installation and operational cost ), opportunities (expansion in emerging markets, and increasing demand for non-invasive techniques) and challenge (Technological and procedural limitations associated with standalone preclinical imaging systems)
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the preclinical imaging market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of preclinical imaging solutions across regions.
• Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the preclinical imaging market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the preclinical imaging market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS & EXCLUSIONS OF STUDY
• 1.4 MARKET SCOPE
  • 1.4.1 MARKET SEGMENTATION
  • FIGURE 1 PRECLINICAL IMAGING MARKET SEGMENTATION
  • 1.4.2 REGIONAL SCOPE
• 1.5 YEARS CONSIDERED
• 1.6 CURRENCY CONSIDERED
  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
• 1.7 LIMITATIONS
• 1.8 STAKEHOLDERS
• 1.9 SUMMARY OF CHANGES
  • 1.9.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 2 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primary interviews
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 5 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 6 PRECLINICAL IMAGING MARKET: COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION
  • FIGURE 7 PRECLINICAL IMAGING MARKET: BOTTOM-UP APPROACH
  • FIGURE 8 PRECLINICAL IMAGING MARKET: TOP-DOWN APPROACH
• 2.3 GROWTH FORECAST
  • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PRECLINICAL IMAGING MARKET (2024-2029)
  • FIGURE 10 PRECLINICAL IMAGING MARKET: CAGR PROJECTIONS
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 MARKET FORECAST
  • TABLE 2 FACTOR ANALYSIS
• 2.7 RISK ANALYSIS
• 2.8 RECESSION IMPACT ANALYSIS
  • TABLE 3 GLOBAL INFLATION RATE PROJECTIONS, 2021-2028 (% GROWTH)
  • TABLE 4 US: HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
  • TABLE 5 US: HEALTH EXPENDITURE, 2023-2030 (USD MILLION)

3 EXECUTIVE SUMMARY

• FIGURE 12 PRECLINICAL IMAGING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 PRECLINICAL IMAGING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 PRECLINICAL IMAGING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 GEOGRAPHIC SNAPSHOT OF PRECLINICAL IMAGING MARKET

4 PREMIUM INSIGHTS

• 4.1 PRECLINICAL IMAGING MARKET OVERVIEW
  • FIGURE 16 TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR IMAGING TO DRIVE MARKET
• 4.2 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT AND COUNTRY (2023)
  • FIGURE 17 IMAGING SYSTEMS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PRECLINICAL IMAGING MARKET IN 2023
• 4.3 PRECLINICAL IMAGING SYSTEMS MARKET: REGIONAL MIX
  • FIGURE 18 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
• 4.4 PRECLINICAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.5 PRECLINICAL IMAGING MARKET: DEVELOPED VS. EMERGING ECONOMIES
  • FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 21 PRECLINICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Technological advancements in molecular imaging
    • 5.2.1.2 Increasing demand for noninvasive small-animal imaging techniques
    • 5.2.1.3 Growing number of public-private initiatives and funding to support preclinical imaging
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Stringent regulations governing preclinical research
    • 5.2.2.2 Significant installation and operational costs associated with preclinical imaging modalities
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Emerging markets to offer growth opportunities
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Technological and procedural limitations associated with standalone preclinical imaging systems
• 5.3 INDUSTRY TRENDS
  • 5.3.1 IMAGING BIOMARKERS
  • 5.3.2 MULTIMODAL IMAGING
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Photoacoustic tomography - MRI technology
    • 5.4.1.2 Multispectral optoacoustic tomography
  • 5.4.2 ADJACENT TECHNOLOGIES
    • 5.4.2.1 Contrast agents
    • 5.4.2.2 Magnetic particle imaging
  • 5.4.3 COMPLEMENTARY TECHNOLOGIES
    • 5.4.3.1 Molecular imaging
  • 5.4.4 PRICING ANALYSIS
    • 5.4.4.1 Average selling price trend, by region
  • TABLE 6 AVERAGE SELLING PRICE TREND OF PRECLINICAL IMAGING SYSTEMS, BY REGION
    • 5.4.4.2 Average selling price trend of key players, by product
  • TABLE 7 AVERAGE SELLING PRICE OF PRECLINICAL IMAGING PRODUCTS
• 5.5 VALUE CHAIN ANALYSIS
  • FIGURE 22 PRECLINICAL IMAGING MARKET: VALUE CHAIN ANALYSIS:
• 5.6 ECOSYSTEM ANALYSIS
  • FIGURE 23 PRECLINICAL IMAGING MARKET: ECOSYSTEM ANALYSIS
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 8 PRECLINICAL IMAGING MARKET: PORTER'S FIVE FORCES
  • FIGURE 24 PRECLINICAL IMAGING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 BARGAINING POWER OF BUYERS
  • 5.7.2 BARGAINING POWER OF SUPPLIERS
  • 5.7.3 THREAT OF NEW ENTRANTS
  • 5.7.4 THREAT OF SUBSTITUTES
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 REGULATORY LANDSCAPE
  • 5.8.1 NORTH AMERICA
    • 5.8.1.1 US
  • TABLE 9 US FDA: CLASSIFICATION OF MEDICAL DEVICES
    • 5.8.1.2 Canada
  • TABLE 10 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • 5.8.2 EUROPE
  • 5.8.3 ASIA PACIFIC
    • 5.8.3.1 Japan
  • TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
    • 5.8.3.2 China
  • TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
    • 5.8.3.3 India
  • 5.8.4 LATIN AMERICA
    • 5.8.4.1 Brazil
  • 5.8.5 MIDDLE EAST & AFRICA
    • 5.8.5.1 UAE
  • 5.8.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.9 PATENT ANALYSIS
  • 5.9.1 PATENT PUBLICATION TRENDS
  • 5.9.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PRECLINICAL IMAGING PATENTS
  • FIGURE 25 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PRECLINICAL IMAGING PATENTS, 2013-2023
  • 5.9.3 MAJOR PATENTS
  • FIGURE 26 MAJOR PATENTS FOR PRECLINICAL IMAGING (2013-2023)
  • 5.9.4 LIST OF PATENTS/PATENT APPLICATIONS
• 5.10 TRADE ANALYSIS
  • 5.10.1 TRADE ANALYSIS FOR PRECLINICAL IMAGING SYSTEMS
  • FIGURE 27 PRODUCT IMPORTS UNDER HSN CODE 901813, BY COUNTRY, 2022 (USD THOUSAND)
  • FIGURE 28 PRODUCT EXPORTS UNDER HSN CODE 901813, BY COUNTRY, 2022 (USD THOUSAND)
• 5.11 CASE STUDY ANALYSIS
  • TABLE 16 CASE STUDY 1: PRECLINICAL DEVELOPMENT AND FIRST-IN-HUMAN STUDY OF 68GA-DOTA-MLN6907
  • TABLE 17 CASE STUDY 2: ACCELERATING PRECLINICAL ANALYSIS OF OCULAR DISEASES
  • TABLE 18 CASE STUDY 3: USAGE OF CRYO-FLUORESCENCE TOMOGRAPHY
• 5.12 KEY CONFERENCES & EVENTS, 2023-2024
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRECLINICAL IMAGING SYSTEMS
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRECLINICAL IMAGING SYSTEMS, BY TYPE
  • 5.13.2 BUYING CRITERIA
  • FIGURE 29 KEY BUYING CRITERIA FOR PRECLINICAL IMAGING SYSTEMS, BY TYPE
  • TABLE 21 KEY BUYING CRITERIA FOR PRECLINICAL IMAGING SYSTEMS
• 5.14 UNMET NEEDS ANALYSIS
  • TABLE 22 UNMET NEEDS IN PRECLINICAL IMAGING MARKET
  • 5.14.1 END-USER EXPECTATIONS
  • TABLE 23 END-USER EXPECTATIONS IN PRECLINICAL IMAGING MARKET
• 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.16 REIMBURSEMENT SCENARIO
  • TABLE 24 US: MEDICAL REIMBURSEMENT CPT CODES FOR PRECLINICAL IMAGING PROCEDURES (AS OF 2021)
• 5.17 BUSINESS MODEL ANALYSIS
• 5.18 INVESTMENT AND FUNDING SCENARIO
  • FIGURE 31 FUNDING OF PLAYERS IN PRECLINICAL IMAGING MARKET, 2023

6 PRECLINICAL IMAGING MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 25 PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 26 PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
• 6.2 IMAGING SYSTEMS
  • TABLE 27 PRECLINICAL IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS
  • TABLE 28 PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 29 PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • 6.2.1 OPTICAL IMAGING SYSTEMS
  • TABLE 30 OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 31 OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • 6.2.1.1 Bioluminescence imaging systems
      • 6.2.1.1.1 Advanced imaging techniques to propel adoption
  • TABLE 32 BIOLUMINESCENT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 33 BIOLUMINESCENCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.1.2 Fluorescence imaging systems
      • 6.2.1.2.1 Integration with other imaging modalities to support market growth
  • TABLE 34 FLUORESCENCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 35 FLUORESCENCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.1.3 Other optical imaging systems
  • TABLE 36 OTHER OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 37 OTHER OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.2.2 NUCLEAR IMAGING SYSTEMS
  • TABLE 38 NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 39 NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 40 NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 41 NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.2.1 Micro-PET imaging systems
  • TABLE 42 MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 43 MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 44 MICRO-PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 45 MICRO-PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.2.1.1 Standalone PET imaging systems
      • 6.2.2.1.1.1 Development of technologically advanced multimodality PET/CT imaging systems to limit market growth
  • TABLE 46 STANDALONE PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 47 STANDALONE PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.2.1.2 PET/CT imaging systems
      • 6.2.2.1.2.1 Expanding applications to aid market growth
  • TABLE 48 PET/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 49 PET/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.2.1.3 PET/MRI imaging systems
      • 6.2.2.1.3.1 Absence of ionizing radiations to aid market growth
  • TABLE 50 PET/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 51 PET/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.2.2 Micro-SPECT imaging systems
  • TABLE 52 MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 53 MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 54 MICRO-SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 55 MICRO-SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.2.2.1 SPECT/CT imaging systems
      • 6.2.2.2.1.1 Wide applications in oncology research to drive market
  • TABLE 56 SPECT/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 57 SPECT/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.2.2.2 SPECT/MRI imaging systems
      • 6.2.2.2.2.1 Enhanced sensitivity to aid market growth
  • TABLE 58 SPECT/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 59 SPECT/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.2.2.3 Standalone SPECT imaging systems
      • 6.2.2.2.3.1 Lower sensitivity and longer scan times to limit market growth
  • TABLE 60 STANDALONE SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 61 STANDALONE SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.2.3 Trimodality (SPECT/PET/CT) imaging systems
      • 6.2.2.3.1 High resolution of systems to drive adoption
  • TABLE 62 TRIMODALITY (SPECT/PET/CT) IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 63 TRIMODALITY (SPECT/PET/CT) IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.2.3 MICRO-MRI SYSTEMS
    • 6.2.3.1 Technological advancements to support market growth
  • TABLE 64 MICRO-MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 65 MIRCO-MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.2.4 MICRO-ULTRASOUND SYSTEMS
    • 6.2.4.1 Portable and cost-effective-key factors driving their adoption
  • TABLE 66 MICRO-ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 67 MICRO-ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.2.5 MICRO-CT SYSTEMS
    • 6.2.5.1 Technical advancements in X-ray sources and X-ray imaging arrays to support market growth
  • TABLE 68 MICRO-CT SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 69 MICRO-CT SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.2.6 PHOTOACOUSTIC IMAGING SYSTEMS
    • 6.2.6.1 Rising number of research studies for development of cancer therapeutics to drive market
  • TABLE 70 PHOTOACOUSTIC IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 71 PHOTOACOUSTIC IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.2.7 MAGNETIC PARTICLE IMAGING SYSTEMS
    • 6.2.7.1 Exceptional spatial resolution and sensitivity to aid market growth
  • TABLE 72 MAGNETIC PARTICLE IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 73 MAGNETIC PARTICLE IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
• 6.3 REAGENTS
  • TABLE 74 PRECLINICAL IMAGING REAGENTS OFFERED BY KEY MARKET PLAYERS
  • TABLE 75 PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 76 PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • 6.3.1 OPTICAL IMAGING REAGENTS
  • TABLE 77 OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 78 OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 79 OPTICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 80 OPTICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.1.1 Bioluminescent imaging reagents
  • TABLE 81 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 82 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 83 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 84 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.1.1.1 Luciferin
      • 6.3.1.1.1.1 Used in preclinical molecular imaging of gene expression in cell cultures, individual cells, and whole organisms
  • TABLE 85 LUCIFERIN MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 86 LUCIFERIN MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.1.1.2 Coelenterazine
      • 6.3.1.1.2.1 Lower bioavailability to limit market growth
  • TABLE 87 COELENTERAZINE MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 88 COELENTERAZINE MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.1.1.3 Furimazine
      • 6.3.1.1.3.1 Superior sensitivity and stability compared to traditional luciferase substrates enhance data accuracy
  • TABLE 89 FURIMAZINE MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 90 FURIMAZINE MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.1.2 Fluorescent imaging reagents
  • TABLE 91 FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 92 FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 93 FLUORESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 94 FLUORESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.1.2.1 Green fluorescent proteins
      • 6.3.1.2.1.1 Noninvasive visualization to drive market growth
  • TABLE 95 GREEN FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 96 GREEN FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.1.2.2 Red fluorescent proteins
      • 6.3.1.2.2.1 Growing use of RFPs in preclinical research to support market growth
  • TABLE 97 RED FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 98 RED FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.1.2.3 Infrared dyes
      • 6.3.1.2.3.1 Advancements in infrared imaging technology to propel market
  • TABLE 99 INFRARED DYES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 100 INFRARED DYES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.3.2 NUCLEAR IMAGING REAGENTS
  • TABLE 101 NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 102 NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 103 NUCLEAR IMAGING REAGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 104 NUCLEAR IMAGING REAGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.1 PET tracers
  • TABLE 105 PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 106 PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 107 PET TRACERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 108 PET TRACERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.1.1 Fluorine-18-based PET Tracers
      • 6.3.2.1.1.1 Most preferred PET tracer due to longer half-life
  • TABLE 109 FLUORINE-18-BASED PET TRACERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 110 FLUORINE-18-BASED PET TRACERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.1.2 Carbon-11-based PET Tracers
      • 6.3.2.1.2.1 Shorter half-life makes syntheses and commercial distribution difficult and complex
  • TABLE 111 CARBON-11-BASED PET TRACERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 112 CARBON-11-BASED PET TRACERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.1.3 Copper-64-based PET Tracers
      • 6.3.2.1.3.1 Low initial positron energy makes it suitable for imaging
  • TABLE 113 COPPER-64-BASED PET TRACERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 114 COPPER-64-BASED PET TRACERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.1.4 Other PET tracers
  • TABLE 115 OTHER PET TRACERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 116 OTHER PET TRACERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.2 SPECT probes
  • TABLE 117 SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 118 SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 119 SPECT PROBES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 120 SPECT PROBES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.2.1 Technetium-99m-based SPECT Probes
      • 6.3.2.2.1.1 Wide usage in various applications to support market growth
  • TABLE 121 TECHNETIUM-99M-BASED SPECT PROBES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 122 TECHNETIUM-99M-BASED SPECT PROBES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.2.2 Iodine-131-based SPECT Probes
      • 6.3.2.2.2.1 High risk of radiation hazards limits utilization in preclinical research studies
  • TABLE 123 IODINE-131-BASED SPECT PROBES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 124 IODINE-131-BASED SPECT PROBES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.2.3 Gallium-67-based SPECT Probes
      • 6.3.2.2.3.1 Widely used in nuclear imaging to study inflammation and chronic tumors
  • TABLE 125 GALLIUM-67-BASED SPECT PROBES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 126 GALLIUM-67-BASED SPECT PROBES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.2.4 Thallium-201-based SPECT Probes
      • 6.3.2.2.4.1 Longer half-life and low radiation dose to support market growth
  • TABLE 127 THALLIUM-201-BASED SPECT PROBES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 128 THALLIUM-201-BASED SPECT PROBES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2.2.5 Other SPECT probes
  • TABLE 129 OTHER SPECT PROBES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 130 OTHER SPECT PROBES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.3.3 MRI CONTRAST AGENTS
  • TABLE 131 MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 132 MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 133 MRI CONTRAST AGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 134 MRI CONTRAST AGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.3.1 Gadolinium-based contrast agents
      • 6.3.3.1.1 Rising number of research studies on neurological disorders to drive market
  • TABLE 135 GADOLINIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 136 GADOLINIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.3.2 Iron-based contrast agents
      • 6.3.3.2.1 Increasing number of research studies for development of novel cancer therapeutics to propel market
  • TABLE 137 IRON-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 138 IRON-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.3.3 Manganese-based contrast agents
      • 6.3.3.3.1 Toxicity of gadolinium-based contrast agents to drive demand
  • TABLE 139 MANGANESE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 140 MANGANESE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.3.4 ULTRASOUND CONTRAST AGENTS
    • 6.3.4.1 Advancements in ultrasound technology to support market growth
  • TABLE 141 ULTRASOUND CONTRAST AGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 142 ULTRASOUND CONTRAST AGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.3.5 CT CONTRAST AGENTS
  • TABLE 143 CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 144 CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 145 CT CONTRAST AGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 146 CT CONTRAST AGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.5.1 Iodine-based contrast agents
      • 6.3.5.1.1 Advancements in CT imaging technology to drive market
  • TABLE 147 IODINE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 148 IODINE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.5.2 Barium-based contrast agents
      • 6.3.5.2.1 Limited number of ongoing gastrointestinal research activities to hamper market growth
  • TABLE 149 BARIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 150 BARIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.5.3 Gold nanoparticles
      • 6.3.5.3.1 Advantages of gold nanoparticles over other CT contrast agents to increase demand
  • TABLE 151 GOLD NANOPARTICLES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 152 GOLD NANOPARTICLES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.5.4 Gastrografin-based contrast agents
      • 6.3.5.4.1 Used for imaging of gastrointestinal tract
  • TABLE 153 GASTROGRAFIN-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 154 GASTROGRAFIN-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
• 6.4 SOFTWARE
  • 6.4.1 ADVANCES IN IMAGING TECHNOLOGIES NECESSITATE ADVANCED SOFTWARE FOR DATA HANDLING AND ANALYSIS
  • TABLE 155 PRECLINICAL IMAGING SOFTWARE OFFERED BY KEY MARKET PLAYERS
  • TABLE 156 PRECLINICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 157 PRECLINICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023-2029 (USD MILLION)

7 PRECLINICAL IMAGING MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • TABLE 158 PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 159 PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• 7.2 ONCOLOGY
  • 7.2.1 GROWING FOCUS ON DEVELOPMENT OF ONCOLOGY THERAPEUTICS TO DRIVE MARKET
  • TABLE 160 PRECLINICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 161 PRECLINICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2029 (USD MILLION)
• 7.3 CARDIOLOGY
  • 7.3.1 INCREASED FOCUS ON TARGETED TREATMENTS FOR CVD TO PROPEL MARKET
  • TABLE 162 PRECLINICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 163 PRECLINICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2023-2029 (USD MILLION)
• 7.4 NEUROLOGY
  • 7.4.1 INCREASING PREVALENCE OF NEUROLOGICAL DISORDERS TO SUPPORT MARKET GROWTH
  • TABLE 164 PRECLINICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 165 PRECLINICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2029 (USD MILLION)
• 7.5 INFECTIOUS DISEASES
  • 7.5.1 RISING PREVALENCE OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH
  • TABLE 166 PRECLINICAL IMAGING MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 167 PRECLINICAL IMAGING MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2029 (USD MILLION)
• 7.6 IMMUNOLOGY & INFLAMMATION
  • 7.6.1 ADVANCEMENTS IN IMMUNOTHERAPY RESEARCH TO PROPEL MARKET
  • TABLE 168 PRECLINICAL IMAGING MARKET FOR IMMUNOLOGY & INFLAMMATION, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 169 PRECLINICAL IMAGING MARKET FOR IMMUNOLOGY & INFLAMMATION, BY COUNTRY, 2023-2029 (USD MILLION)
• 7.7 OTHER APPLICATIONS
  • TABLE 170 PRECLINICAL IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 171 PRECLINICAL IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2029 (USD MILLION)

8 PRECLINICAL IMAGING MARKET, BY END USER

• 8.1 INTRODUCTION
  • TABLE 172 PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 173 PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
• 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.2.1 MAJOR END USERS DUE TO EXTENSIVE INVOLVEMENT IN DRUG DISCOVERY AND DEVELOPMENT PROCESSES
  • TABLE 174 PRECLINICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 175 PRECLINICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2029 (USD MILLION)
• 8.3 ACADEMIC & RESEARCH CENTERS
  • 8.3.1 GROWING AVAILABILITY OF RESEARCH GRANTS AND FUNDING TO DRIVE MARKET
  • TABLE 176 PRECLINICAL IMAGING MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 177 PRECLINICAL IMAGING MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2023-2029 (USD MILLION)
• 8.4 IMAGING CENTERS
  • 8.4.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO PROPEL MARKET
  • TABLE 178 PRECLINICAL IMAGING MARKET FOR IMAGING CENTERS, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 179 PRECLINICAL IMAGING MARKET FOR IMAGING CENTERS, BY COUNTRY, 2023-2029 (USD MILLION)
• 8.5 OTHER END USERS
  • TABLE 180 PRECLINICAL IMAGING MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 181 PRECLINICAL IMAGING MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2029 (USD MILLION)

9 PRECLINICAL IMAGING MARKET, BY REGION

• 9.1 INTRODUCTION
  • TABLE 182 PRECLINICAL IMAGING MARKET, BY REGION, 2018-2022 (USD MILLION)
  • TABLE 183 PRECLINICAL IMAGING MARKET, BY REGION, 2023-2029 (USD MILLION)
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: RECESSION IMPACT
  • FIGURE 32 NORTH AMERICA: PRECLINICAL IMAGING MARKET SNAPSHOT
  • TABLE 184 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 185 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 186 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 187 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 188 NORTH AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 189 NORTH AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 190 NORTH AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 191 NORTH AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 192 NORTH AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 193 NORTH AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 194 NORTH AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2018-2022 (USD MILLION)
  • TABLE 195 NORTH AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2023-2029 (USD MILLION)
  • TABLE 196 NORTH AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 197 NORTH AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 198 NORTH AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 199 NORTH AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 200 NORTH AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 201 NORTH AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 202 NORTH AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 203 NORTH AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 204 NORTH AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 205 NORTH AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 206 NORTH AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 207 NORTH AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 208 NORTH AMERICA: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 209 NORTH AMERICA: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 210 NORTH AMERICA: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 211 NORTH AMERICA: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 212 NORTH AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 213 NORTH AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 214 NORTH AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 215 NORTH AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 216 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 217 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 218 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 219 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)

• 9.2.2 US
  • 9.2.2.1 Rapid adoption of technologically advanced imaging systems to drive growth
• TABLE 220 US: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
• TABLE 221 US: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
• TABLE 222 US: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 223 US: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 224 US: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 225 US: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 226 US: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 227 US: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 228 US: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 229 US: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 230 US: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 231 US: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 232 US: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 233 US: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 234 US: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 235 US: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 236 US: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 237 US: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 238 US: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 239 US: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 240 US: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 241 US: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 242 US: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 243 US: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 244 US: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 245 US: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 246 US: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 247 US: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 248 US: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 249 US: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 250 US: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 251 US: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 252 US: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 253 US: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
• 9.2.3 CANADA
  • 9.2.3.1 Growth in stem cell research activities to support market growth
• TABLE 254 CANADA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
• TABLE 255 CANADA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
• TABLE 256 CANADA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 257 CANADA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 258 CANADA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 259 CANADA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 260 CANADA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 261 CANADA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 262 CANADA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 263 CANADA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 264 CANADA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 265 CANADA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 266 CANADA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 267 CANADA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 268 CANADA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 269 CANADA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 270 CANADA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 271 CANADA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 272 CANADA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 273 CANADA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 274 CANADA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 275 CANADA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 276 CANADA: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 277 CANADA: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 278 CANADA: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 279 CANADA: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 280 CANADA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 281 CANADA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 282 CANADA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 283 CANADA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 284 CANADA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 285 CANADA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 286 CANADA: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 287 CANADA: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
• 9.3 EUROPE
  • 9.3.1 EUROPE: RECESSION IMPACT
  • TABLE 288 EUROPE: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 289 EUROPE: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 290 EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 291 EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 292 EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 293 EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 294 EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 295 EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 296 EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 297 EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 298 EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 299 EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 300 EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 301 EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 302 EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 303 EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 304 EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 305 EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 306 EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 307 EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 308 EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 309 EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 310 EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 311 EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 312 EUROPE: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 313 EUROPE: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 314 EUROPE: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 315 EUROPE: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 316 EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 317 EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 318 EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 319 EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 320 EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 321 EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 322 EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 323 EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 9.3.2 GERMANY
    • 9.3.2.1 Growth in biotechnology industry to propel market
  • TABLE 324 GERMANY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 325 GERMANY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 326 GERMANY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 327 GERMANY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 328 GERMANY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 329 GERMANY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 330 GERMANY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 331 GERMANY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 332 GERMANY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 333 GERMANY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 334 GERMANY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 335 GERMANY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 336 GERMANY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 337 GERMANY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 338 GERMANY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 339 GERMANY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 340 GERMANY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 341 GERMANY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 342 GERMANY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 343 GERMANY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 344 GERMANY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 345 GERMANY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 346 GERMANY: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 347 GERMANY: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 348 GERMANY: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 349 GERMANY: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 350 GERMANY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 351 GERMANY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 352 GERMANY: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 353 GERMANY: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 354 GERMANY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 355 GERMANY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 356 GERMANY: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 357 GERMANY: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 9.3.3 UK
    • 9.3.3.1 Increasing focus on cancer research to drive market
  • TABLE 358 UK: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 359 UK: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 360 UK: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 361 UK: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 362 UK: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 363 UK: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 364 UK: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 365 UK: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 366 UK: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 367 UK: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 368 UK: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 369 UK: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 370 UK: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 371 UK: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 372 UK: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 373 UK: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 374 UK: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 375 UK: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 376 UK: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 377 UK: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 378 UK: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 379 UK: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 380 UK: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 381 UK: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 382 UK: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 383 UK: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 384 UK: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 385 UK: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 386 UK: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 387 UK: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 388 UK: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 389 UK: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 390 UK: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 391 UK: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 9.3.4 FRANCE
    • 9.3.4.1 Increased investments in proteomics and genomics to fuel market growth
  • TABLE 392 FRANCE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 393 FRANCE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 394 FRANCE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 395 FRANCE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 396 FRANCE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 397 FRANCE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 398 FRANCE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 399 FRANCE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 400 FRANCE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 401 FRANCE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 402 FRANCE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 403 FRANCE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 404 FRANCE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 405 FRANCE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 406 FRANCE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 407 FRANCE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 408 FRANCE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 409 FRANCE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 410 FRANCE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 411 FRANCE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 412 FRANCE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 413 FRANCE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 414 FRANCE: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 415 FRANCE: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 416 FRANCE: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 417 FRANCE: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 418 FRANCE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 419 FRANCE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 420 FRANCE: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 421 FRANCE: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 422 FRANCE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 423 FRANCE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 424 FRANCE: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 425 FRANCE: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 9.3.5 ITALY
    • 9.3.5.1 Growth in biotechnology and pharmaceutical industries to drive market
  • TABLE 426 ITALY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 427 ITALY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 428 ITALY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 429 ITALY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 430 ITALY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 431 ITALY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 432 ITALY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 433 ITALY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 434 ITALY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 435 ITALY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 436 ITALY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 437 ITALY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 438 ITALY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 439 ITALY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 440 ITALY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 441 ITALY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 442 ITALY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 443 ITALY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 444 ITALY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 445 ITALY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 446 ITALY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 447 ITALY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 448 ITALY: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 449 ITALY: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 450 ITALY: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 451 ITALY: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 452 ITALY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 453 ITALY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 454 ITALY: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 455 ITALY: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 456 ITALY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 457 ITALY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 458 ITALY: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 459 ITALY: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 9.3.6 SPAIN
    • 9.3.6.1 Extensive R&D pipeline to support market growth
  • TABLE 460 SPAIN: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 461 SPAIN: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 462 SPAIN: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 463 SPAIN: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 464 SPAIN: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 465 SPAIN: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 466 SPAIN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 467 SPAIN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 468 SPAIN: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 469 SPAIN: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 470 SPAIN: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 471 SPAIN: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 472 SPAIN: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 473 SPAIN: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 474 SPAIN: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 475 SPAIN: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 476 SPAIN: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 477 SPAIN: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 478 SPAIN: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 479 SPAIN: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 480 SPAIN: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 481 SPAIN: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 482 SPAIN: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 483 SPAIN: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 484 SPAIN: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 485 SPAIN: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 486 SPAIN: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 487 SPAIN: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 488 SPAIN: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 489 SPAIN: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 490 SPAIN: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 491 SPAIN: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 492 SPAIN: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 493 SPAIN: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 9.3.7 REST OF EUROPE
  • TABLE 494 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 495 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 496 REST OF EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 497 REST OF EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 498 REST OF EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 499 REST OF EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 500 REST OF EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 501 REST OF EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 502 REST OF EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2018-2022 (USD MILLION)
  • TABLE 503 REST OF EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2023-2029 (USD MILLION)
  • TABLE 504 REST OF EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 505 REST OF EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 506 REST OF EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 507 REST OF EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 508 REST OF EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 509 REST OF EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 510 REST OF EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 511 REST OF EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 512 REST OF EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 513 REST OF EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 514 REST OF EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 515 REST OF EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 516 REST OF EUROPE: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 517 REST OF EUROPE: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 518 REST OF EUROPE: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 519 REST OF EUROPE: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 520 REST OF EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 521 REST OF EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 522 REST OF EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 523 REST OF EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 524 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 525 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 526 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 527 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
  • FIGURE 33 ASIA PACIFIC: PRECLINICAL IMAGING MARKET SNAPSHOT
  • TABLE 528 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 529 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 530 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 531 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 532 ASIA PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 533 ASIA PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 534 ASIA PACIFIC: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 535 ASIA PACIFIC: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 536 ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 537 ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 538 ASIA PACIFIC: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 539 ASIA PACIFIC: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 540 ASIA PACIFIC: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 541 ASIA PACIFIC: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 542 ASIA PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 543 ASIA PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 544 ASIA PACIFIC: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 545 ASIA PACIFIC: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 546 ASIA PACIFIC: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 547 ASIA PACIFIC: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 548 ASIA PACIFIC: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 549 ASIA PACIFIC: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 550 ASIA PACIFIC: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 551 ASIA PACIFIC: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 552 ASIA PACIFIC: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 553 ASIA PACIFIC: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 554 ASIA PACIFIC: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 555 ASIA PACIFIC: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 556 ASIA PACIFIC: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 557 ASIA PACIFIC: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 558 ASIA PACIFIC: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 559 ASIA PACIFIC: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 560 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 561 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 562 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 563 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)

• 9.4.2 JAPAN
  • 9.4.2.1 Increasing focus on personalized diagnostic products to support market growth
• TABLE 564 JAPAN: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
• TABLE 565 JAPAN: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
• TABLE 566 JAPAN: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 567 JAPAN: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 568 JAPAN: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 569 JAPAN: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 570 JAPAN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 571 JAPAN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 572 JAPAN: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 573 JAPAN: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 574 JAPAN: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 575 JAPAN: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 576 JAPAN: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 577 JAPAN: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 578 JAPAN: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 579 JAPAN: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 580 JAPAN: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 581 JAPAN: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 582 JAPAN: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 583 JAPAN: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 584 JAPAN: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 585 JAPAN: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 586 JAPAN: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 587 JAPAN: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 588 JAPAN: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 589 JAPAN: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 590 JAPAN: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 591 JAPAN: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 592 JAPAN: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 593 JAPAN: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 594 JAPAN: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 595 JAPAN: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 596 JAPAN: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 597 JAPAN: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
• 9.4.3 CHINA
  • 9.4.3.1 Fastest-growing pharmaceutical market-key factor driving market
• TABLE 598 CHINA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
• TABLE 599 CHINA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
• TABLE 600 CHINA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 601 CHINA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 602 CHINA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 603 CHINA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 604 CHINA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 605 CHINA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 606 CHINA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 607 CHINA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 608 CHINA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 609 CHINA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 610 CHINA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 611 CHINA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 612 CHINA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 613 CHINA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 614 CHINA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 615 CHINA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 616 CHINA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 617 CHINA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 618 CHINA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 619 CHINA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 620 CHINA: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 621 CHINA: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 622 CHINA: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 623 CHINA: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 624 CHINA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 625 CHINA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 626 CHINA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 627 CHINA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 628 CHINA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 629 CHINA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 630 CHINA: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 631 CHINA: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
• 9.4.4 INDIA
  • 9.4.4.1 Favorable government policies to propel market
• TABLE 632 INDIA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
• TABLE 633 INDIA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
• TABLE 634 INDIA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 635 INDIA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 636 INDIA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 637 INDIA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 638 INDIA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 639 INDIA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 640 INDIA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 641 INDIA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 642 INDIA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 643 INDIA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 644 INDIA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 645 INDIA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 646 INDIA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 647 INDIA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 648 INDIA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 649 INDIA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 650 INDIA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 651 INDIA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 652 INDIA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 653 INDIA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 654 INDIA: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 655 INDIA: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 656 INDIA: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 657 INDIA: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 658 INDIA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 659 INDIA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 660 INDIA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 661 INDIA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 662 INDIA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 663 INDIA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 664 INDIA: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 665 INDIA: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
• 9.4.5 REST OF ASIA PACIFIC
• TABLE 666 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
• TABLE 667 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
• TABLE 668 REST OF ASIA PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 669 REST OF ASIA PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 670 REST OF ASIA PACIFIC: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 671 REST OF ASIA PACIFIC: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 672 REST OF ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 673 REST OF ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 674 REST OF ASIA PACIFIC: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 675 REST OF ASIA PACIFIC: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 676 REST OF ASIA PACIFIC: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 677 REST OF ASIA PACIFIC: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 678 REST OF ASIA PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 679 REST OF ASIA PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 680 REST OF ASIA PACIFIC: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 681 REST OF ASIA PACIFIC: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 682 REST OF ASIA PACIFIC: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 683 REST OF ASIA PACIFIC: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 684 REST OF ASIA PACIFIC: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 685 REST OF ASIA PACIFIC: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 686 REST OF ASIA PACIFIC: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 687 REST OF ASIA PACIFIC: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 688 REST OF ASIA PACIFIC: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 689 REST OF ASIA PACIFIC: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 690 REST OF ASIA PACIFIC: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 691 REST OF ASIA PACIFIC: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 692 REST OF ASIA PACIFIC: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 693 REST OF ASIA PACIFIC: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 694 REST OF ASIA PACIFIC: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
• TABLE 695 REST OF ASIA PACIFIC: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
• TABLE 696 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 697 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 698 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 699 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
• 9.5 LATIN AMERICA
  • 9.5.1 LATIN AMERICA: RECESSION IMPACT
  • TABLE 700 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 701 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 702 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 703 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 704 LATIN AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 705 LATIN AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 706 LATIN AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 707 LATIN AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 708 LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 709 LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 710 LATIN AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 711 LATIN AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 712 LATIN AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 713 LATIN AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 714 LATIN AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 715 LATIN AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 716 LATIN AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 717 LATIN AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 718 LATIN AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 719 LATIN AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 720 LATIN AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 721 LATIN AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 722 LATIN AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 723 LATIN AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 724 LATIN AMERICA: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 725 LATIN AMERICA: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 726 LATIN AMERICA: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 727 LATIN AMERICA: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 728 LATIN AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 729 LATIN AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 730 LATIN AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 731 LATIN AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 732 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 733 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 734 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 735 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 9.5.2 BRAZIL
    • 9.5.2.1 Increasing Investments in Biopharmaceutical research to propel market
  • TABLE 736 BRAZIL: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 737 BRAZIL: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 738 BRAZIL: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 739 BRAZIL: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 740 BRAZIL: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 741 BRAZIL: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 742 BRAZIL: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 743 BRAZIL: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 744 BRAZIL: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 745 BRAZIL: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 746 BRAZIL: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 747 BRAZIL: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 748 BRAZIL: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 749 BRAZIL: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 750 BRAZIL: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 751 BRAZIL: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 752 BRAZIL: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 753 BRAZIL: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 754 BRAZIL: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 755 BRAZIL: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 756 BRAZIL: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 757 BRAZIL: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 758 BRAZIL: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 759 BRAZIL: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 760 BRAZIL: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 761 BRAZIL: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 762 BRAZIL: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 763 BRAZIL: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 764 BRAZIL: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 765 BRAZIL: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 766 BRAZIL: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 767 BRAZIL: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 768 BRAZIL: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 769 BRAZIL: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 9.5.3 MEXICO
    • 9.5.3.1 Booming pharmaceutical and biotechnology industry to drive market
  • TABLE 770 MEXICO: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 771 MEXICO: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 772 MEXICO: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 773 MEXICO: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 774 MEXICO: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 775 MEXICO: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 776 MEXICO: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 777 MEXICO: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 778 MEXICO: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 779 MEXICO: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 780 MEXICO: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 781 MEXICO: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 782 MEXICO: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 783 MEXICO: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 784 MEXICO: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 785 MEXICO: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 786 MEXICO: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 787 MEXICO: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 788 MEXICO: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 789 MEXICO: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 790 MEXICO: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 791 MEXICO: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 792 MEXICO: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 793 MEXICO: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 794 MEXICO: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 795 MEXICO: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 796 MEXICO: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 797 MEXICO: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 798 MEXICO: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 799 MEXICO: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 800 MEXICO: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 801 MEXICO: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 802 MEXICO: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 803 MEXICO: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 9.5.4 REST OF LATIN AMERICA
  • TABLE 804 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 805 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 806 REST OF LATIN AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 807 REST OF LATIN AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 808 REST OF LATIN AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 809 REST OF LATIN AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 810 REST OF LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 811 REST OF LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 812 REST OF LATIN AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 813 REST OF LATIN AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 814 REST OF LATIN AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 815 REST OF LATIN AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 816 REST OF LATIN AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 817 REST OF LATIN AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 818 REST OF LATIN AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 819 REST OF LATIN AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 820 REST OF LATIN AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 821 REST OF LATIN AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 822 REST OF LATIN AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 823 REST OF LATIN AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 824 REST OF LATIN AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 825 REST OF LATIN AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 826 REST OF LATIN AMERICA: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 827 REST OF LATIN AMERICA: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 828 REST OF LATIN AMERICA: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 829 REST OF LATIN AMERICA: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 830 REST OF LATIN AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 831 REST OF LATIN AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 832 REST OF LATIN AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 833 REST OF LATIN AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 834 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 835 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 836 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 837 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • TABLE 838 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 839 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 840 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018-2022 (USD MILLION)
  • TABLE 841 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 842 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 843 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 844 MIDDLE EAST & AFRICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 845 MIDDLE EAST & AFRICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 846 MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 847 MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 848 MIDDLE EAST & AFRICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 849 MIDDLE EAST & AFRICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 850 MIDDLE EAST & AFRICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 851 MIDDLE EAST & AFRICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 852 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 853 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 854 MIDDLE EAST & AFRICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 855 MIDDLE EAST & AFRICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 856 MIDDLE EAST & AFRICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 857 MIDDLE EAST & AFRICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 858 MIDDLE EAST & AFRICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 859 MIDDLE EAST & AFRICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 860 MIDDLE EAST & AFRICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 861 MIDDLE EAST & AFRICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 862 MIDDLE EAST & AFRICA: PET TRACERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 863 MIDDLE EAST & AFRICA: PET TRACERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 864 MIDDLE EAST & AFRICA: SPECT PROBES MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 865 MIDDLE EAST & AFRICA: SPECT PROBES MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 866 MIDDLE EAST & AFRICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 867 MIDDLE EAST & AFRICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 868 MIDDLE EAST & AFRICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
  • TABLE 869 MIDDLE EAST & AFRICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 870 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 871 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 872 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 873 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023-2029 (USD MILLION)
• 9.6.2 GCC COUNTRIES
  • 9.6.2.1 Increasing research activities to support market growth
  • TABLE 874 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
  • TABLE 875 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 876 GCC COUNTRIES: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 877 GCC COUNTRIES: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 878 GCC COUNTRIES: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 879 GCC COUNTRIES: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 880 GCC COUNTRIES: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 881 GCC COUNTRIES: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 882 GCC COUNTRIES: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 883 GCC COUNTRIES: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 884 GCC COUNTRIES: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 885 GCC COUNTRIES: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 886 GCC COUNTRIES: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 887 GCC COUNTRIES: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 888 GCC COUNTRIES: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 889 GCC COUNTRIES: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 890 GCC COUNTRIES: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 891 GCC COUNTRIES: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 892 GCC COUNTRIES: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 893 GCC COUNTRIES: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 894 GCC COUNTRIES: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 895 GCC COUNTRIES: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 896 GCC COUNTRIES: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 897 GCC COUNTRIES: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 898 GCC COUNTRIES: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 899 GCC COUNTRIES: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 900 GCC COUNTRIES: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 901 GCC COUNTRIES: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 902 GCC COUNTRIES: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 903 GCC COUNTRIES: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 904 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
  • TABLE 905 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
  • TABLE 906 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 907 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
• 9.6.3 REST OF MIDDLE EAST & AFRICA
• TABLE 908 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION)
• TABLE 909 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
• TABLE 910 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 911 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 912 REST OF MIDDLE EAST & AFRICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 913 REST OF MIDDLE EAST & AFRICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 914 REST OF MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 915 REST OF MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 916 REST OF MIDDLE EAST & AFRICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 917 REST OF MIDDLE EAST & AFRICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 918 REST OF MIDDLE EAST & AFRICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 919 REST OF MIDDLE EAST & AFRICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 920 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 921 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 922 REST OF MIDDLE EAST & AFRICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 923 REST OF MIDDLE EAST & AFRICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 924 REST OF MIDDLE EAST & AFRICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 925 REST OF MIDDLE EAST & AFRICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 926 REST OF MIDDLE EAST & AFRICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 927 REST OF MIDDLE EAST & AFRICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 928 REST OF MIDDLE EAST & AFRICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 929 REST OF MIDDLE EAST & AFRICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 930 REST OF MIDDLE EAST & AFRICA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 931 REST OF MIDDLE EAST & AFRICA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 932 REST OF MIDDLE EAST & AFRICA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 933 REST OF MIDDLE EAST & AFRICA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 934 REST OF MIDDLE EAST & AFRICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 935 REST OF MIDDLE EAST & AFRICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 936 REST OF MIDDLE EAST & AFRICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
• TABLE 937 REST OF MIDDLE EAST & AFRICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
• TABLE 938 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
• TABLE 939 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
• TABLE 940 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION)
• TABLE 941 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGY/ RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PRECLINICAL IMAGING MARKET
  • FIGURE 34 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES
• 10.3 REVENUE ANALYSIS
• FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN PRECLINICAL IMAGING MARKET, 2019–2023 (USD MILLION)
• 10.4 MARKET SHARE ANALYSIS
• FIGURE 36 PRECLINICAL IMAGING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023
• TABLE 942 PRECLINICAL IMAGING MARKET: DEGREE OF COMPETITION
• 10.5 RANKING OF KEY MARKET PLAYERS
• FIGURE 37 RANKING OF KEY PLAYERS IN THE PRECLINICAL IMAGING MARKET, 2023
• 10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.6.1 STARS
  • 10.6.2 EMERGING LEADERS
  • 10.6.3 PERVASIVE PLAYERS
  • 10.6.4 PARTICIPANTS
  • FIGURE 38 PRECLINICAL IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • 10.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.6.5.1 Company footprint
    • TABLE 943 PRECLINICAL IMAGING MARKET: COMPANY FOOTPRINT
    • 10.6.5.2 Product footprint
    • TABLE 944 PRECLINICAL IMAGING MARKET: PRODUCT FOOTPRINT
    • 10.6.5.3 Application footprint
    • TABLE 945 PRECLINICAL IMAGING MARKET: APPLICATION FOOTPRINT
    • 10.6.5.4 End-user footprint
    • TABLE 946 PRECLINICAL IMAGING MARKET: END-USER FOOTPRINT
    • 10.6.5.5 Region footprint
    • TABLE 947 PRECLINICAL IMAGING MARKET: REGION FOOTPRINT
• 10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.7.1 PROGRESSIVE COMPANIES
  • 10.7.2 RESPONSIVE COMPANIES
  • 10.7.3 DYNAMIC COMPANIES
  • 10.7.4 STARTING BLOCKS
  • FIGURE 39 PRECLINICAL IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • 10.7.5 COMPETITIVE BENCHMARKING: STARTUP/SME PLAYERS
  • TABLE 948 PRECLINICAL IMAGING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 949 PRECLINICAL IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING STARTUPS/SMES
• 10.8 VALUATION AND FINANCIAL METRICS
• FIGURE 40 EV/EBITDA OF KEY VENDORS
• FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• 10.9 BRAND/PRODUCT COMPARISON
• FIGURE 42 PRECLINICAL IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• 10.10 COMPETITIVE SCENARIO
  • 10.10.1 PRODUCT LAUNCHES
  • TABLE 950 PRECLINICAL IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
  • 10.10.2 DEALS 585
  • TABLE 951 PRECLINICAL IMAGING MARKET: DEALS, JANUARY 2021–MAY 2024
  • 10.10.3 EXPANSIONS 585
  • TABLE 952 PRECLINICAL IMAGING MARKET: EXPANSIONS, JANUARY 2021–MAY 2024

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
• (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
  • 11.1.1 BRUKER CORPORATION
  • TABLE 953 BRUKER CORPORATION: COMPANY OVERVIEW
  • FIGURE 43 BRUKER CORPORATION: COMPANY SNAPSHOT (2023)
  • TABLE 954 BRUKER CORPORATION: PRODUCTS OFFERED
  • TABLE 955 BRUKER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
  • TABLE 956 BRUKER CORPORATION: DEALS, JANUARY 2021–MAY 2024
  • 11.1.2 REVVITY, INC.
  • TABLE 957 REVVITY, INC.: COMPANY OVERVIEW 591
  • FIGURE 44 REVVITY, INC.: COMPANY SNAPSHOT (2023)
  • TABLE 958 REVVITY, INC.: PRODUCTS OFFERED 592
  • TABLE 959 REVVITY, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
  • 11.1.3 OPTISCAN IMAGING LTD.
  • TABLE 960 OPTISCAN IMAGING LTD.: COMPANY OVERVIEW 595
  • FIGURE 45 OPTISCAN IMAGING LTD.: COMPANY SNAPSHOT (2023)
  • TABLE 961 OPTISCAN IMAGING LTD.: PRODUCTS OFFERED 596
  • 11.1.4 MEDISO LTD.
  • TABLE 962 MEDISO LTD.: COMPANY OVERVIEW
  • TABLE 963 MEDISO LTD.: PRODUCTS OFFERED
  • TABLE 964 MEDISO LTD.: EXPANSIONS, JANUARY 2021–MAY 2024
  • 11.1.5 ASPECT IMAGING LTD.
  • TABLE 965 ASPECT IMAGING LTD.: COMPANY OVERVIEW
  • TABLE 966 ASPECT IMAGING LTD.: PRODUCTS OFFERED 59
  • 11.1.6 MR SOLUTIONS
  • TABLE 967 MR SOLUTIONS: COMPANY OVERVIEW
  • TABLE 968 MR SOLUTIONS: PRODUCTS OFFERED
  • 11.1.7 TRIFOIL IMAGING
  • TABLE 969 TRIFOIL IMAGING: COMPANY OVERVIEW
  • TABLE 970 TRIFOIL IMAGING: PRODUCTS OFFERED
  • 11.1.8 MILABS B.V.
  • TABLE 971 MILABS B.V.: COMPANY OVERVIEW
  • TABLE 972 MILABS B.V.: PRODUCTS OFFERED
  • TABLE 973 MILABS B.V.: DEALS, JANUARY 2021–MAY 2024
  • 11.1.9 CUBRESA INC.
  • TABLE 974 CUBRESA INC.: COMPANY OVERVIEW
  • TABLE 975 CUBRESA INC.: PRODUCTS OFFERED
  • 11.1.10 BERTHOLD TECHNOLOGIES GMBH & CO. KG
  • TABLE 976 BERTHOLD TECHNOLOGIES GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 977 BERTHOLD TECHNOLOGIES GMBH & CO. KG: PRODUCTS OFFERED
  • 11.1.11 ADVANCED MOLECULAR VISION, INC.
  • TABLE 978 ADVANCED MOLECULAR VISION, INC.: COMPANY OVERVIEW
  • TABLE 979 ADVANCED MOLECULAR VISION, INC.: PRODUCTS OFFERED
  • 11.1.12 SOFIE
  • TABLE 980 SOFIE: COMPANY OVERVIEW
  • TABLE 981 SOFIE: PRODUCTS OFFERED
  • 11.1.13 ICONEUS
  • TABLE 982 ICONEUS: COMPANY OVERVIEW
  • TABLE 983 ICONEUS: PRODUCTS OFFERED
  • 11.1.14 FUJIFILM VISUALSONICS, INC.
  • TABLE 984 FUJIFILM VISUALSONICS, INC.: COMPANY OVERVIEW
  • TABLE 985 FUJIFILM VISUALSONICS, INC.: PRODUCTS OFFERED
  • TABLE 986 FUJIFILM VISUALSONICS, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
  • TABLE 987 FUJIFILM VISUALSONICS, INC.: DEALS, JANUARY 2021–MAY 2024
  • 11.1.15 LI-COR BIOTECH, LLC
  • TABLE 988 LI-COR BIOTECH, LLC: COMPANY OVERVIEW
  • TABLE 989 LI-COR BIOTECH, LLC: PRODUCTS OFFERED
  • 11.1.16 IVIM TECHNOLOGY CORP.
  • TABLE 990 IVIM TECHNOLOGY CORP.: COMPANY OVERVIEW
  • TABLE 991 IVIM TECHNOLOGY CORP.: PRODUCTS OFFERED
  • 11.1.17 KUB TECHNOLOGIES
  • TABLE 992 KUB TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 993 KUB TECHNOLOGIES: PRODUCTS OFFERED
  • 11.1.18 MEDIKORS INC.
  • TABLE 994 MEDIKORS INC.: COMPANY OVERVIEW
  • TABLE 995 MEDIKORS INC.: PRODUCTS OFFERED
  • 11.1.19 VIEWORKS CO., LTD.
  • TABLE 996 VIEWORKS CO., LTD.: COMPANY OVERVIEW
  • TABLE 997 VIEWORKS CO., LTD.: PRODUCTS OFFERED
  • TABLE 998 VIEWORKS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
  • 11.1.20 AI4R
  • TABLE 999 AI4R: COMPANY OVERVIEW
  • TABLE 1000 AI4R: PRODUCTS OFFERED
  • 11.2 OTHER PLAYERS
    • 11.2.1 ANALYTIK JENA GMBH + CO. KG
    • 11.2.2 ITHERA MEDICAL GMBH
    • 11.2.3 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
    • 11.2.4 HAWKCELL SAS
    • 11.2.5 MILTENYI BIOTEC
    • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS